Esperion Therapeutics, Inc. (ESPR) has 151 open-market insider trades by 32 insiders since 2013. Over the last six months insiders net sold $240K. The most active filer is Eric Warren, Chief Commercial Officer.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Dov A. Goldstein M.D. | Dir | — | 3 | $93.5M | 2018-06-06 |
| Patrick G. Enright | Dir | — | 3 | $59.2M | 2015-03-19 |
| Daniel Janney | Dir | — | 4 | $45.3M | 2021-05-27 |
| Biotech Ag Bb | 10% Owner | — | 11 | $37.4M | 2021-05-24 |
| Target N. V. Biotech | 10% Owner | — | 8 | $25.4M | 2020-11-03 |
| Capital Partners Llc Aisling | 10% | — | 1 | $23.5M | 2015-04-24 |
| Brian K. Halak | 10% | — | 2 | $14.0M | 2014-10-21 |
| Guy P. Nohra | 10% | — | 1 | $10.0M | 2014-10-21 |
| Nicole Vitullo | Dir | — | 6 | $8.0M | 2023-06-15 |
| Boxer Asset Management Inc. | 10% Owner | — | 1 | $6.8M | 2018-11-05 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Benjamin Looker | CLO | Sell | $37K | 2026-06-17 |
| Sheldon L. Koenig | CEO & President | Sell | $169K | 2026-06-17 |
| Benjamin Halladay | CFO | Sell | $34K | 2026-06-17 |
| Benjamin Halladay | CFO | Sell | $35K | 2026-03-17 |
| Benjamin Looker | CLO | Sell | $31K | 2026-03-17 |
| Sheldon L. Koenig | CEO & President | Sell | $139K | 2026-03-17 |
Companies that share insiders with ESPR, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Benjamin Looker | General Counsel | Sell | $5K | 2026-01-20 |
| Sheldon L. Koenig | CEO & President | Sell | $354K | 2025-12-17 |
| Benjamin Looker | General Counsel | Sell | $24K | 2025-12-17 |
| Benjamin Halladay | CFO | Sell | $27K | 2025-12-17 |
| Benjamin Looker | General Counsel | Sell | $3K | 2025-10-17 |
| Benjamin Looker | General Counsel | Sell | $18K | 2025-09-17 |
| Benjamin Halladay | CFO | Sell | $20K | 2025-09-17 |
| Sheldon L. Koenig | CEO & President | Sell | $159K | 2025-09-17 |
| Benjamin Looker | General Counsel | Sell | $1K | 2025-07-17 |